Tallinn Childrens' Hospital

Tallinn 13419

1 studies enrolling now · 12 studies all time

What they study most

Crohn's Disease, Epilepsy, Complex Partial, Gram-negative Bacterial Infection, Growth Hormone Deficiency in Children, Haemophilia A and B With and Without Inhibitors, Juvenile Myoclonic Epilepsy, Muscular Atrophy, Spinal, Neonatal Sepsis, Respiratory Tract Infections, Short Stature Children Born Small for Gestational Age (SGA), Urinary Bladder, Neurogenic

Studies at this site

• Biology of Juvenile Myoclonic Epilepsy — Recruiting now
• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors — Running, not enrolling
• A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day — Running, not enrolling
• A Research Study in Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day (REAL4) — Completed
• A Study to Learn About the Long-Term Safety of Higher Doses of Nusinersen (BIIB058) Given as Injections to Participants With Spinal Muscular Atrophy (SMA) Who Took Part in an Earlier Nusinersen Trial (ONWARD) — Running, not enrolling
• Late-onset Sepsis in Term and Pre-term Neonates and Infants up to 3 Months of Age — Completed
• Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy — Completed
• A Study of Rilematovir in Infants and Children and Subsequently in Neonates Hospitalized With Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus (RSV) — Stopped early
• Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants. — Stopped early
• A Study To Find Out How Fesoterodine Works In Children Aged 6 To 17 Years With Bladder Overactivity Caused By A Neurological Condition — Completed
• Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy — Completed